Detalles de la búsqueda
1.
Early histological transformation of follicular lymphoma to diffuse large B-cell lymphoma indicating adverse survival: A population-based analysis and validation.
Cancer
; 2024 May 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-38809573
2.
Outcome of malignant lymphoma in Ukraine. Analysis of 563 cases registered in the Ukrainian Lymphoma Registry in 2019-2021.
Br J Haematol
; 204(5): 1757-1761, 2024 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-38400556
3.
Bendamustine and rituximab as first-line treatment for symptomatic splenic marginal zone lymphoma: long-term outcome and impact of early unmeasurable minimal residual disease attainment from the BRISMA/IELSG36 phase II study.
Haematologica
; 2024 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-38497158
4.
Relapse patterns in early-PET negative, limited-stage Hodgkin lymphoma (HL) after ABVD with or without radiotherapy-a joint analysis of EORTC/LYSA/FIL H10 and NCRI RAPID trials.
Br J Haematol
; 200(6): 731-739, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36541117
5.
Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell Project.
Blood
; 138(3): 213-220, 2021 07 22.
Artículo
en Inglés
| MEDLINE | ID: mdl-34292324
6.
Distribution of lymphoma subtypes in Ukraine according to the WHO 2016 classification.
Hematol Oncol
; 41(1): 196-200, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-35932211
7.
Impact of immunochemotherapy with R-bendamustine or R-CHOP for treatment naïve advanced-stage follicular lymphoma: A subset analysis of the FOLL12 trial by Fondazione Italiana Linfomi.
Hematol Oncol
; 41(4): 655-662, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37246287
8.
Breast Cancer Prevention: The Key Role of Population Screening, Breast Self-Examination (BSE) and Technological Tools. Survey of Italian Women.
J Cancer Educ
; 38(5): 1728-1742, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-37400725
9.
End of induction positron emission tomography complete response (PET-CR) as a surrogate for progression-free survival in previously untreated follicular lymphoma.
Br J Haematol
; 198(2): 333-337, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35491747
10.
High-risk stage IIB Hodgkin lymphoma treated in the H10 and AHL2011 trials: total metabolic tumor volume is a useful risk factor to stratify patients at baseline.
Haematologica
; 107(12): 2897-2904, 2022 12 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35638548
11.
Autologous stem-cell transplantation as consolidation of first-line chemotherapy in patients with peripheral T-cell lymphoma: a multicenter GELTAMO/FIL study.
Haematologica
; 107(11): 2675-2684, 2022 11 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-35320921
12.
Characteristics and clinical outcomes of patients with ALK-positive anaplastic large cell lymphoma: Report from the prospective international T-cell lymphoma project.
Hematol Oncol
; 40(5): 953-961, 2022 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-36083035
13.
Long-term results of the MCL01 phase II trial of rituximab plus HyperCVAD alternating with high-dose cytarabine and methotrexate for the initial treatment of patients with mantle cell lymphoma.
Br J Haematol
; 192(6): 1011-1014, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-32410259
14.
Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Hematol Oncol
; 39(3): 293-303, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-33742718
15.
Four versus six cycles of CHOP chemotherapy in combination with six applications of rituximab in patients with aggressive B-cell lymphoma with favourable prognosis (FLYER): a randomised, phase 3, non-inferiority trial.
Lancet
; 394(10216): 2271-2281, 2019 12 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-31868632
16.
Prognostic model for high-tumor-burden follicular lymphoma integrating baseline and end-induction PET: a LYSA/FIL study.
Blood
; 131(22): 2449-2453, 2018 05 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-29559480
17.
Prognostic value of baseline metabolic tumor volume in early-stage Hodgkin lymphoma in the standard arm of the H10 trial.
Blood
; 131(13): 1456-1463, 2018 03 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-29437590
18.
Improving the international prognostic index score using peripheral blood counts: Results of a large multicenter study involving 520 patients with diffuse large B cell lymphoma.
Hematol Oncol
; 38(4): 439-445, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32495944
19.
Incidence and outcomes of rare T cell lymphomas from the T Cell Project: hepatosplenic, enteropathy associated and peripheral gamma delta T cell lymphomas.
Am J Hematol
; 95(2): 151-155, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31709579
20.
Outcomes for Relapsed and Refractory Peripheral T-Cell Lymphoma Patients after Front-Line Therapy from the COMPLETE Registry.
Acta Haematol
; 143(1): 40-50, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-31315113